Literature DB >> 25896297

Stem cell therapies for systemic lupus erythematosus: current progress and established evidence.

Dandan Wang1, Lingyun Sun.   

Abstract

Systemic lupus erythematosus is a multisystem autoimmune disease that, despite the advances in immunosuppressive medical therapies, remains potentially fatal in some patients, especially in treatment-refractory patients. In recent years, hematopoietic stem cells and, most recently, mesenchymal stem cells have been used to treat drug-resistant cases. Some progress was made, but there are still some issues to be resolved in the clinic.

Entities:  

Keywords:  hematopoietic stem cells; immunomodulation; mesenchymal stem cells; systemic lupus erythematosus; transplantation

Mesh:

Year:  2015        PMID: 25896297     DOI: 10.1586/1744666X.2015.1037741

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  2 in total

1.  Mesenchymal Stem Cells Activate the MEK/ERK Signaling Pathway and Enhance DNA Methylation via DNMT1 in PBMC from Systemic Lupus Erythematosus.

Authors:  Hui Xiong; Zhixuan Guo; Zengqi Tang; Xuechen Ai; Qing Qi; Xiuting Liu; Danqi Huang; Zhaofeng Li; Suyun Ji; Qing Guo
Journal:  Biomed Res Int       Date:  2020-11-17       Impact factor: 3.411

2.  A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus.

Authors:  Dandan Wang; Huayong Zhang; Jun Liang; Hong Wang; Bingzhu Hua; Xuebing Feng; Gary S Gilkeson; Dominique Farge; Songtao Shi; Lingyun Sun
Journal:  Stem Cell Reports       Date:  2018-03-01       Impact factor: 7.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.